Gnanasekaran Deepika, Pandurangan Aadhithya Raaj, Ramaswamy Pradeepan Sengiah, Raghavendra Shrunga Kandhi, Raman Karthick, Somasundaram Gowri Shankar
Department of Internal Medicine, Hillingdon Hospital, Uxbridge, London, United Kingdom.
Department of Internal Medicine, Madras Medical College, Chennai, Tamil Nadu, India.
Bioinformation. 2024 Dec 31;20(12):1900-1903. doi: 10.6026/9732063002001900. eCollection 2024.
The relationship between gut microbiota composition and the development of cardiovascular disease, with a potential role of microbial metabolites in inflammatory and metabolic pathways is of interest. We analyzed gut microbiota and markers of cardiovascular health in a cohort of 100 participants for three years to search for microbial signatures correlated with increased CVD risk. Our results show several correlations between specific microbial taxa, lipid metabolism and systemic inflammation, whereby a higher Firmicutes/Bacteroides ratio is associated with a greater incidence of CVD. These results suggest that intervention targeting the microbiome has the potential to reduce risk for CVD and point towards a role for gut microbiota in cardiovascular health.
肠道微生物群组成与心血管疾病发展之间的关系备受关注,其中微生物代谢产物在炎症和代谢途径中可能发挥作用。我们对100名参与者组成的队列进行了为期三年的肠道微生物群和心血管健康标志物分析,以寻找与心血管疾病风险增加相关的微生物特征。我们的结果显示了特定微生物分类群、脂质代谢和全身炎症之间的几种相关性,其中厚壁菌门/拟杆菌门比例较高与心血管疾病的发生率较高相关。这些结果表明,针对微生物群的干预措施有可能降低心血管疾病风险,并表明肠道微生物群在心血管健康中发挥作用。
Bioinformation. 2024-12-31
Metabolites. 2021-7-29
Ann Med Surg (Lond). 2024-1-18
Naunyn Schmiedebergs Arch Pharmacol. 2025-4-9
J Tradit Complement Med. 2021-9-22
World J Cardiol. 2020-4-26
Ann Med Surg (Lond). 2024-1-18
Nat Rev Cardiol. 2023-6
Annu Rev Physiol. 2023-2-10
J Cardiovasc Transl Res. 2023-6
Front Cell Infect Microbiol. 2022
Signal Transduct Target Ther. 2022-4-23
Front Cell Infect Microbiol. 2021
Metabolism. 2021-4